• Print
  • Email

Rule 10b-5/Section 11 Securities Class Actions

Cornerstone Research has provided rigorous financial and statistical analysis and expert testimony in all phases of Rule 10b-5 and Section 11 matters. Drawing on decades of academic research on security price formation, we have developed innovative approaches to evaluating alternative per-share damages scenarios in Rule 10b-5 and Section 11 and 12 claims. Our staff and affiliated experts consistently have defined leading methods involving issues of class certification, loss causation, and damages in thousands of cases across a wide range of industries.

Trial Experience

Cornerstone Research has provided consulting and expert testimony in several prominent securities trials. We have worked closely with attorneys to develop effective trial strategies.

JDS Uniphase Corporation Securities Litigation

Everex Securities Litigation

Biogen Securities Litigation

American Pacific Securities Litigation

Seagate Technology II Securities Litigation

Equitec Rollup Litigation

Summary Judgment and Daubert Challenges

Our analyses addressing loss causation, market efficiency, and the appropriate analytical framework to address these issues have led to successful summary judgment decisions and Daubert challenges.

In re Boston Scientific Corporation Securities Litigation

Omnicom Group Inc. Securities Litigation

Xcelera Securities Litigation

Danis v. USN Communications, Inc., et al.

Worlds of Wonder Securities Litigation

Loss Causation

Drawing on decades of academic research on security price formation, we have developed innovative approaches to evaluating loss causation and damages scenarios. The approaches developed by our experts have been accepted by the courts in a number of cases and have come to define the standard required by courts.

In re Broadcom Securities Litigation

Allen T. Gilliland Trust et al. v. H&F MobileMedia Partners, LLC, et al.

AST Research Securities Litigation

Tri-Star Pictures Securities Litigation

SEC v. Biopure Corporation

Failure to Disclose Clinical Trial Results

Misleading Statements Regarding Drug Safety

Misleading Disclosure of Clinical Trial Results

Class Action Trends

Cornerstone Research and the Stanford Law School cosponsor the Securities Class Action Clearinghouse, the leading source of data and analysis on the financial and economic characteristics of federal securities fraud class action litigation.

Post-Reform Act Filings

Post-Reform Act Settlements

Securities Class Action Clearinghouse

Fixed Income

Our securities expertise includes matters involving complex fixed income securities.

Mortgage-Backed Securities and Collateralized Debt Obligations (CDOs)

High-Yield Debt

Bond Default Litigation